KCT0007598招募中未知
Biomarker Study of Immune Checkpoint Inhibitors in Metastatic Head and Neck Squamous Cell Carcinoma
ational Cancer Center0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 20(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1. Metastatic HNSCC patients who are expected to undergo monotherapy of nivolumab or pembrolizumab
- •2. Expected survival is at least 12 weeks
- •3. Patient must provide informed consent.
排除标准
- •1. Patients with poor performance status (ECOG 3 or 4), and with an expected survival of 12 weeks or shorter.
- •2. Patients who were previously diagnosed with another type of malignancy within 5 years of study enrollment date.
- •3. Previous treatment history with immune checkpoint inhibitors (including anti-CTLA4 antibodies)
- •4. Patients who do not consent to this study
- •5. Patients who are not feasible to obtain study samples
- •6. Patients who are not feasible for thorough communication
- •7. Patients who do not consent to using their samples for subsequent research purposes
研究者
相似试验
已完成
不适用
Efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer other than adenocarcinoma or squamous cell carcinoma: multicenter retrospective observational studyon-small cell lung cancer other than adenocarcinoma or squamous cell carcinomaJPRN-UMIN000037777Hamamatsu University School of Medicine60
招募中
不适用
Cohort study of immune-checkpoint-inhibitor antibody treatment in non-small-cell lung cancernon-small-cell lung cancerJPRN-UMIN000020719Saitama Medical University International Medical Center100
已完成
不适用
The usefulness of immune checkpoint inhibitors among lung cancer patients with driver gene mutantsung cancerJPRN-UMIN000040789Yokohama City University
招募中
Unknown
A real-world study of efficacy and safety of Immune check point inhibitors in patients with non-small cell lung cancer harboring driver oncogene excepting EGFRJPRN-UMIN000049022orth East Japan Study Group870
进行中（未招募）
2 期
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial CarcinomaLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial CarcinomaLocally Advanced Urethral Urothelial CarcinomaLocally Advanced Urothelial CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis Urothelial CarcinomaMetastatic Ureter Urothelial CarcinomaMetastatic Urethral Urothelial CarcinomaMetastatic Urothelial CarcinomaStage IV Bladder Cancer AJCC v8Stage IV Renal Pelvis Cancer AJCC v8Stage IV Ureter Cancer AJCC v8Stage IV Urethral Cancer AJCC v8NCT04848519Emory University6